MC

Mahesh Chimanlal Dalal

Active Director Director DIN 00165912
DIN 00165912 First appointment Sep 1984 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 15 historical roles
Total affiliations 16 Since Sep 1984
Shareholding value •••• Premium profile

About Mahesh Chimanlal Dalal

Data last updated:

Mahesh Chimanlal Dalal is a Director at Jen-Pharma Products Private Limited (since 1995). The companies operate in Chemicals and Materials, Financial Services and Infrastructure and Utilities. Jen-Pharma Products Private Limited reported revenue of ₹3.68 Cr (FY 2025). Earlier, Mahesh Chimanlal Dalal was a Director at Suptaswar Investments And Trading Company Limited (2007–2024) and Director at Murahar Investments And Trading Company Limited (2007–2024) and 13 more.

DIN 00165912
Primary Designation Director
Industry Chemicals and Materials
First Appointment 29 Sep 1984
Oldest Company Age 39 yrs
Largest company Jen-Pharma Products Private Limited · ₹3.68 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jen-Pharma Products Private Limited U24230MH1995PTC091446
Director07 Aug 19951995₹3.68 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Oct 20071979₹6.93 Cr (FY 2019)Active
Director29 Oct 20071979₹5.68 Cr (FY 2019)Active
Elcid Investments Limited L65990MH1981PLC025770
Director29 Sep 19841981₹236 Cr (FY 2024)Active
Director29 Oct 20031979₹40.98 Cr (FY 2025)Active
Director29 Oct 20031982₹42.28 Cr (FY 2025)Active
Verona Infrastructure Limited U45202MH2008PLC185344
Director01 Aug 20082008Strike Off
Director16 Jul 20101980₹23.44 Cr (FY 2025)Active
Anuja Infrastructrue Private Limited U45203MH2007PTC176036
Additional Director05 Mar 20092007Active
Director21 Jul 20082007Strike Off
Cmm Limited U51900MH1987PLC042684
Director30 Jun 20071987Strike Off
Director24 Apr 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Mahesh Chimanlal Dalal

Directorship timeline

Open interactive timeline →
Jen-Pharma Products Private Limited
Umbergaon Infrastructure And Developers Private Limited
Cmm Limited
Volte-Face Brand Management Private Limited
Premium access

Shareholding and investment profile for Mahesh Chimanlal Dalal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Chimanlal Dalal

Mahesh Chimanlal Dalal currently holds 1 directorship: Jen-Pharma Products Private Limited (Director, since 07 Aug 1995, revenue ₹3.68 Cr (FY 2025)).

Mahesh Chimanlal Dalal was first appointed on 29 Sep 1984 as Director at Elcid Investments Limited. The most recent appointment on record is 24 Apr 2012 at Volte-Face Brand Management Private Limited.

Mahesh Chimanlal Dalal held 15 earlier board appointments: Suptaswar Investments And Trading Company Limited (Director, 29 Oct 2007 to 31 Mar 2024); Murahar Investments And Trading Company Limited (Director, 29 Oct 2007 to 31 Mar 2024); Elcid Investments Limited (Director, 29 Sep 1984 to 31 Mar 2024); Nehal Trading And Investments Private Limited (Director, 29 Oct 2003 to 01 Dec 2015); Jalaj Trading And Investment Co Pvt Ltd (Director, 29 Oct 2003 to 01 Dec 2015); and 10 more.

The current boards of Mahesh Chimanlal Dalal's companies include Krishnakant Sunderlal Parikh (Jen-Pharma Products Private Limited), Nijen Brijendra Desai (Jen-Pharma Products Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available